Abstract:Ordered mesoporous carbon is a kind of novel carrier for intracellular drug release. There are few reports on the use of mesoporous carbon nanospheres (MCNs) as the transmembrane deliverer in human cancer cells; on the other hand, the particle size of MCNs synthesized by hard templates is usually larger than 100 nm. It is accepted that the optimal size of a transmembrane delivery vehicle should be less than 100 nm in diameter and the surface should be hydrophilic to circumvent clearance by macrophages, to maximize circulation times and targeting ability. In this work, MCNs with a diameter of ca. 90 nm have been developed as a targeted drug delivery system of an anticancer drug, doxorubicin (DOX). The small MCNs were synthesized using triblock copolymer Pluronic F127 as a template. The MCNs were first treated by acid to improve its dispersion property in an aqueous solution, and then modified by folic acid through EDC-NHS. The structure of the MCNs was well characterized by transmission electron microscopy, small-angle X-ray scattering, nitrogen adsorption/desorption and dynamic light scattering, pH-dependent drug release is successfully achieved due to the supramolecular pi-pi stacking between DOX and the carbonaceous structures. By effective passive and active targeting, MCNs can be readily internalized into HeLa cells, where the carried DOX can be efficiently released in the acidic microenvironment of the tumors for further therapy. The results from confocal laser scanning microscope and flow cytometry demonstrated that the cellular uptake efficiency of MCNs toward HeLa cells was increased through the functionalization with folic acid, and the folate modified MCNs show much higher endocytosis properties toward HeLa cells (folate receptor positive) than toward MCF-7 cells (folate receptor negative). The cytotoxicities toward HeLa cells were studied by MTT method, which indicated that the cytotoxicities of DOX loaded mesoporous carbon nanoparticles was also enhanced due to the introduction of folic acid and targeted delivery, while the cytotoxicities of MCNs show very good biocompatibility toward both HeLa and KB cells.

Folate‐decorated Polysaccharide‐doxorubicin Polymer: Synthesis, Characterization, and Activity in HeLa Cells

Synergistic effects of antitumor efficacy <i>via</i> mixed nano-size micelles of multifunctional <i>Bletilla striata</i> polysaccharide-based copolymer and D--tocopheryl polyethylene glycol succinate

Synthesis of Folate-conjugated Stearic Acid Grafted Bletilla Striata Polysaccharides Copolymers and Application for Delivering Antitumor Drugs As a Drug Delivery Carrier

Folate-conjugated beta-cyclodextrin-based polymeric micelles with enhanced doxorubicin antitumor efficacy.

Folate-Mediated And Doxorubicin-Conjugated Poly(Epsilon-Caprolactone)-G-Chondroitin Sulfate Copolymers For Enhanced Intracellular Drug Delivery

Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.

Self-assembled nanoparticles from folate-decorated maleilated pullulan-doxorubicin conjugate for improved drug delivery to cancer cells

Folate-decorated Maleilated Pullulan–doxorubicin Conjugate for Active Tumor-Targeted Drug Delivery

Folic Acid-Targeted Polydopamine-Based Surface Modification of Mesoporous Silica Nanoparticles As Delivery Vehicles for Cancer Therapy

Preparation and properties of tumor-targeting lentinan-oleic acid polymer micelles based on folic acid for adriamycin delivery

Folate Functionalized Mesoporous Carbon Nanospheres As Nanocarrier for Targetted Delivery and Controlled Release of Doxorubicin to HeLa Cells

Preparation and in Vitro Anti-tumor Activity Evaluation of Folate-conjugated Polymeric Micelles Loaded with Doxorubicin

Folate-bearing doxorubicin-loaded magnetic poly(N-isopropylacrylamide) microspheres as a new strategy for cancer therapy.

CD44/Folate Dual Targeting Receptor Reductive Response PLGA-Based Micelles for Cancer Therapy

Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes.

Isomeric Folate-Conjugated Polymeric Micelles Bind to Folate Receptors and Display Anticancer Effects.

Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment

PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy

Preparation of Folate-Modified Pullulan Acetate Nanoparticles for Tumor-Targeted Drug Delivery

Synthesis of folate targeted theranostic cubosomal platform for co-delivery of bismuth oxide and doxorubicin to melanoma in vitro and in vivo

Self-Assembled Folic Acid-Targeted Pectin-Multi-Arm Polyethylene Glycol Nanoparticles for Tumor Intracellular Chemotherapy